Information

Information

TowardPi believes in long-term value and adheres to a democratic company management model, with the spirit of scientists at its core
Your location:
Homepage
/
/
/
NMPA (CFDA) Approval!

NMPA (CFDA) Approval!

  • Categories:News
  • Time of issue:2021-10-01 16:04
  • Views:

(Summary description)It’s exciting to announce that TowardPi has passed NMPA (Chinese National Medical Products Administration) certification for two OCT models: BMizar and Yalkaid! Being one of the biggest markets for ophthalmic devices in the world, China becomes a great start of TowardPi’s international journey!

NMPA (CFDA) Approval!

(Summary description)It’s exciting to announce that TowardPi has passed NMPA (Chinese National Medical Products Administration) certification for two OCT models: BMizar and Yalkaid! Being one of the biggest markets for ophthalmic devices in the world, China becomes a great start of TowardPi’s international journey!

  • Categories:News
  • Time of issue:2021-10-01 16:04
  • Views:
Information

It’s exciting to announce that TowardPi has passed NMPA (Chinese National Medical Products Administration) certification for two OCT models: BMizar and Yalkaid! Being one of the biggest markets for ophthalmic devices in the world, China becomes a great start of TowardPi’s international journey!

Powered by new generation full range swept source technology, we provide OCT and OCTA solution in speed of 100-400K, depth 6-14mm, width 16-24mm, and resolution 3.8 microns. Both models are anterior and posterior combo devices.

Global business will be initiated from year 2022. Specific time depends on local regulations individually. For commercial operation, please contact Dr. Jian Zhou, TowardPi VP of Global affairs.

relevant information

© TowardPi (Beijing) Medical Technology Ltd     京ICP备2021011388号-1   Powered by www.300.cn     View business license